US Map / Ohio
State OH

Clinical Trials in Ohio

Ohio is home to a significant concentration of clinical research activity, with academic medical centers, community hospitals, and specialized research clinics serving as active trial sites across a broad range of medical conditions. The studies listed here have at least one enrolled site in Ohio and represent Phase 1 through Phase 4 research sponsored by NIH, pharmaceutical companies, device manufacturers, and independent investigators.

Right now ClinicalMetric tracks 522 actively recruiting studies with Ohio sites out of 522 registered in total. The busiest research areas in Ohio are Prostate Cancer, Breast Cancer, Ovarian Cancer. Leading sponsors running trials in the state include Ohio State University, Children's Hospital Medical Center, Cincinnati, National Cancer Institute (NCI). By stage, Ohio trials break down as Phase 1 (98), Phase 2 (162), Phase 3 (125), Phase 4 (23).

All trial data is sourced directly from ClinicalTrials.gov and updated daily. Recruiting status, eligibility criteria, enrollment targets, and contact information are included for each study. Patients and caregivers should review the full eligibility criteria on each trial listing — or consult their treating physician — before contacting a study site.

Total Trials
522
Recruiting Now
522
← Back to US Map
Top Conditions in Ohio
Prostate Cancer (9)Breast Cancer (9)Ovarian Cancer (8)Endometrial Cancer (7)Acute Myeloid Leukemia (6)Solid Tumor (6)Pancreatic Cancer (5)Heart Failure (5)Multiple Myeloma (5)Colorectal Cancer (5)Advanced Solid Tumor (5)Stroke (5)

Frequently Asked Questions — Clinical Trials in Ohio

How many clinical trials are currently recruiting in Ohio?
ClinicalMetric currently tracks 522 actively recruiting clinical trials with at least one location in Ohio. The total number of registered studies—including active but not currently enrolling trials—is 522. Trial availability is updated daily from ClinicalTrials.gov, and new studies open enrollment regularly throughout the year.
What types of clinical trials are available in Ohio?
Ohio hosts clinical trials across a broad range of medical conditions, including Prostate Cancer, Breast Cancer, Ovarian Cancer, and many others. Trials range from Phase 1 early-safety studies to Phase 4 post-approval surveillance, as well as observational and behavioral research. Academic medical centers, community hospitals, and specialized research clinics throughout Ohio serve as trial sites for studies sponsored by NIH, pharmaceutical companies, and independent investigators.
How do I join a clinical trial near me in Ohio?
To join a clinical trial in Ohio, browse the recruiting studies listed on this page, review the eligibility criteria for each trial, and contact the study site directly. Your primary care physician or specialist can also refer you to clinical trials relevant to your diagnosis. Many academic medical centers in Ohio maintain dedicated clinical trials offices that can match you with appropriate studies based on your medical profile and diagnosis.

Recruiting Trials in Ohio

NCT04889872 N/A
Recruiting
PROGRESS: Management of Moderate Aortic Stenosis by Clinical Surveillance or TAV...
Condition
Aortic Stenosis, Calcific
Enrollment
2,250 pts
Location
United States, Australia, Canada
Sponsor
Edwards Lifesciences
View Trial →
NCT07519772 Phase 1, Phase 2
Recruiting
A Clinical Study of MK-1045 in People With Non-Hodgkin Lymphoma (MK-1045-008)
Condition
Lymphoma, Non-Hodgkin
Enrollment
280 pts
Location
United States, Argentina, Australia
Sponsor
Merck Sharp & Dohme LLC
View Trial →
NCT06900712 N/A
Recruiting
Positive Processes and Transition to Health - Single-Session (PATH-SS)
Condition
PTSD
Enrollment
45 pts
Location
United States
Sponsor
Case Western Reserve Universit
View Trial →
NCT06636383 N/A
Recruiting
Glycogen Storage Disease Type Ia (GSDIa) Disease Monitoring Program
Condition
Glycogen Storage Disease Type Ia
Enrollment
140 pts
Location
United States, Brazil, Canada
Sponsor
Ultragenyx Pharmaceutical Inc
View Trial →
NCT04592445 N/A
Recruiting
Endovascular Ablation of the Right Greater Splanchnic Nerve in Subjects Having H...
Condition
Heart Failure With Preserved Ejection Fraction (HFpEF
Enrollment
150 pts
Location
United States, Georgia
Sponsor
Axon Therapies, Inc.
View Trial →
NCT05653388 N/A
Recruiting
Metastatic Leiomyosarcoma Biomarker Protocol
Condition
Leiomyosarcoma
Enrollment
200 pts
Location
United States, Australia
Sponsor
University of Michigan Rogel C
View Trial →
NCT07654361 Phase 3
Recruiting
Efficacy and Safety of Aleniglipron in Participants With Obesity or Overweight W...
Condition
Obesity
Enrollment
3,600 pts
Location
United States
Sponsor
Gasherbrum Bio, Inc., a wholly
View Trial →
NCT06555029 N/A
Recruiting
Oral Health Intervention in Adult Primary Care
Condition
Dental Caries
Enrollment
929 pts
Location
United States
Sponsor
Case Western Reserve Universit
View Trial →
NCT05319353 Phase 3
Recruiting
A Study to Evaluate the Safety and Tolerability, Pharmacokinetics, and Antiviral...
Condition
Cytomegalovirus (CMV)
Enrollment
80 pts
Location
United States, Australia, Belgium
Sponsor
Takeda
View Trial →
NCT06001788 Phase 1
Recruiting
Safety and Tolerability of Ziftomenib Combinations in Patients With Relapsed/Ref...
Condition
AML
Enrollment
171 pts
Location
United States, Italy, Spain
Sponsor
Kura Oncology, Inc.
View Trial →
NCT05058651 Phase 2, Phase 3
Recruiting
Evaluating the Addition of the Immunotherapy Drug Atezolizumab to Standard Chemo...
Condition
Advanced Extrapulmonary Neuroendocrine Carcinoma
Enrollment
189 pts
Location
United States
Sponsor
National Cancer Institute (NCI
View Trial →
NCT07266402 Phase 3
Recruiting
A Study to Investigate Efficacy, Safety and Tolerability of Barzolvolimab Versus...
Condition
Chronic Inducible Urticaria
Enrollment
240 pts
Location
United States, Germany, Lithuania
Sponsor
Celldex Therapeutics
View Trial →
NCT06657924 Phase 2
Recruiting
Preoperative Tranexamic Acid (TXA) to Prevent Bleeding in Patients Undergoing Ma...
Condition
Bleeding
Enrollment
394 pts
Location
United States
Sponsor
Kristen Ban
View Trial →
NCT00271180 N/A
Recruiting
Product Performance Report: Evaluate Long-term Reliability & Performance of Medt...
Condition
Arrhythmia
Enrollment
20,000 pts
Location
United States, Australia, Austria
Sponsor
Medtronic
View Trial →
NCT06651580 N/A
Recruiting
Biospecimen Collection to Identify Gene Mutations for High Risk Pancreatic Cance...
Condition
Chronic Pancreatitis
Enrollment
1,600 pts
Location
United States, Australia, Canada
Sponsor
M.D. Anderson Cancer Center
View Trial →
NCT04036188 EARLY_Phase 1
Recruiting
Triamcinolone With Vitamin D Synergistic Efficacy in Psoriasis
Condition
Plaque Psoriasis
Enrollment
24 pts
Location
United States
Sponsor
Wright State University
View Trial →
NCT07784270 Phase 3
Recruiting
A Study to Evaluate Effect of AZD6234 in Adult Participants With Type 2 Diabetes...
Condition
Obesity or Overweight
Enrollment
1,500 pts
Location
United States, Argentina, Australia
Sponsor
AstraZeneca
View Trial →
NCT07110337 N/A
Recruiting
Diagnosing Epilepsy To EffeCT Change
Condition
Epilepsy
Enrollment
210 pts
Location
United States
Sponsor
Epiminder America, Inc.
View Trial →
NCT07402941 N/A
Recruiting
Evaluation of Cochlear (Promontory) Stimulation During Awake Ear Surgery (TONES ...
Condition
Hearing Disorder
Enrollment
18 pts
Location
United States
Sponsor
Auricle Health Inc.
View Trial →
NCT06638502 Phase 1, Phase 2
Recruiting
Safety of HRX215 in Patients After Minor and Major Liver Resection
Condition
Liver Resection
Enrollment
80 pts
Location
United States, France, Germany
Sponsor
HepaRegeniX GmbH
View Trial →
NCT07013474 Phase 3
Recruiting
A Study to Learn About the Study Medicine Ibuzatrelvir in Adults With COVID-19 W...
Condition
COVID-19 Infection
Enrollment
300 pts
Location
United States, Argentina, Belgium
Sponsor
Pfizer
View Trial →
NCT06721520 Phase 2, Phase 3
Recruiting
Effectiveness of Methods for Pyloric Drainage in esophagecTomY: Botox vs. Pyloro...
Condition
Esophageal Cancer Surgery
Enrollment
170 pts
Location
United States
Sponsor
The Cleveland Clinic
View Trial →
NCT05150691 Phase 1, Phase 2
Recruiting
A Phase 1/2a Study of DB-1303/BNT323 in Advanced/Metastatic Solid Tumors
Condition
HER2-positive Advanced Solid Tumor
Enrollment
796 pts
Location
United States, Australia, China
Sponsor
DualityBio Inc.
View Trial →
NCT07424027 N/A
Recruiting
Central Vein Sign in Multiple Sclerosis Extension Study
Condition
Multiple Sclerosis
Enrollment
40 pts
Location
United States
Sponsor
The Cleveland Clinic
View Trial →
NCT07102550 Phase 2
Recruiting
Biliary Anastomosis in Living Donor Liver Transplant With Amniotic Tissue
Condition
Liver Transplant
Enrollment
40 pts
Location
United States
Sponsor
Jaekeun Kim
View Trial →
Page 13 of 21 — 522 trials total
← Prev Next →
ClinicalMetric — Independent clinical trial intelligence platform. Not affiliated with NIH, ClinicalTrials.gov, the U.S. FDA, or any pharmaceutical company, hospital, or clinical research organization. Trial data is sourced from ClinicalTrials.gov for informational purposes only and does not constitute medical advice. Do not make any treatment, enrollment, or health decisions based solely on information found here — always consult a qualified healthcare professional. Full Disclaimer  ·  Last Reviewed: November 2026  ·  Data Methodology